发明名称 |
METHOD OF TREATING MACULAR OEDEMA ACCOMPANYING RETINOVASCULITIS |
摘要 |
FIELD: medicine.SUBSTANCE: ranimizumab is injected through a two-stage self-sealing scleral puncture with a 30G injection needle into a vitreous body at 3.5-4.0mm from the limb. A control optical coherent tomography and a fluorescent angiography of the retina are performed 2-3 weeks later. The persistent ischemia and extravasation regions require a paravasal transpupillar laser retinal coagulation to be performed. The exposure parameters: wave length 659nm, power 0.13-0.15mWt, 100-250 coagulates, exposure 0.1-0.15 s, spot diameter 200mcm. The retina is exposed along the temporal arcades.EFFECT: method enables providing the stable therapeutic effect ensured by relieving or eliminating a macular oeodema with improving the visual functions by suppressing the extravasation and blocking of the ischemic regions in a combination with reducing the anti-inflammatory and haemorrhagic reaction.2 ex |
申请公布号 |
RU2562022(C2) |
申请公布日期 |
2015.09.10 |
申请号 |
RU20130131902 |
申请日期 |
2013.07.11 |
申请人 |
FEDERAL'NOE GOSUDARSTVENNOE BJUDZHETNOE UCHREZHDENIE "MEZHOTRASLEVOJ NAUCHNO-TEKHNICHESKIJ KOMPLEKS"MIKROKHIRURGIJA GLAZA" IMENI AKADEMIKA S.N. FEDOROVA" MINISTERSTVA ZDRAVOOKHRANENIJA ROSSIJSKOJ FEDERATSII |
发明人 |
ZAJTSEVA NATAL'JA VADIMOVNA;BUKINA VERA VASIL'EVNA;SENCHENKO NADEZHDA JAKOVLEVNA;SHCHUKO ANDREJ GENNAD'EVICH |
分类号 |
A61F9/007;A61F9/008;A61K39/395;A61P27/02 |
主分类号 |
A61F9/007 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|